Clinical Trials Browser

Phase 1 × INDUSTRY × Interleukin-18 × Clear all

NCT00500058 2017-07-26

A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18

Phase 1 Completed

Lymphoma, Non-Hodgkin, Neoplasms

NCT00659178 2017-07-21

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Phase 1 Completed

Ovarian Neoplasms

NCT00085878 2008-10-16

Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor Cancer

NCT00085904 2008-10-13

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

Phase 1 Completed

Lymphoma, Neoplasms